vimarsana.com

Latest Breaking News On - Carl johan wachtmeister - Page 1 : vimarsana.com

Hamlet Pharma and SelectImmune Pharma merge to create an innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections

This press release or the merger does not constitute an offer, either directly or indirectly in Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, Singapore, South Africa or the United States, or in any other jurisdiction where such offer under the laws and regulations of such relevant jurisdiction would be prohibited by applicable law. Shareholders who are not resident in Sweden and who wish to accept the proposed merger consideration must carry out closer investigations regarding the applicable legislation and possible tax consequences. The two pharmaceutical companies Hamlet Pharma AB and SelectImmune Pharma AB, listed on the Spotlight Stock Market, intend to merge and create a powerful pharmaceutical company for drug development for the treatment of cancer and infectious diseases. The merged company (Hamlet Biopharma) gets a portfolio with a total of ten pharmaceutical projects, of which three projects are in phase II, where two of the projects already have positive re

Enzymatica launches ColdZyme on Amazon

Enzymatica launches ColdZyme on Amazon STOCKHOLM, June 3, 2021 /PRNewswire/ Enzymatica now launches its common cold spray ColdZyme on Amazon in the UK and Sweden. The E-commerce for health care products has increased during the past years, and in particular during the corona pandemic. This is also valid for ColdZyme. Enzymatica is now carrying out an increased effort for this sales channel, and considers that there are great opportunities by the presence on Amazon. During the past year Amazon has displayed record in sales and in number of new customers. An important factor for the growth has been the demand for health care products, with an increasing number of customers that put their trust in Amazon for purchase of pharmaceuticals, medical device products and supplements.

Bulletin from Annual General Meeting of Enzymatica AB (publ) on 5 May 2021

Bulletin from Annual General Meeting of Enzymatica AB (publ) on 5 May 2021 STOCKHOLM, May 5, 2021 /PRNewswire/ The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Enzymatica AB (publ) (the Company ) held its annual general meeting on 5 May 2021. In order to prevent the spread of the virus causing covid-19, the annual general meeting was carried out solely through postal voting, without any physical presence. At the annual general meeting, the following resolutions were made. Income statements and balance sheets The general meeting resolved to adopt the income statement and the balance sheet as well as the consolidated income statement and the consolidated balance sheet for the fiscal year of 2020.

Enzymatica Publication of the Annual Report 2020

Enzymatica Publication of the Annual Report 2020
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.